Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousBone Marrow TransplantationMultiple MyelomaPeripheral Blood Stem Cell TransplantationTransplantation ConditioningMelphalanAntineoplastic Combined Chemotherapy ProtocolsBone MarrowCombined Modality TherapyTreatment OutcomeBone Marrow CellsRemission InductionSalvage TherapyStem CellsDisease-Free SurvivalCyclophosphamideLymphoma, Non-HodgkinHematopoietic Stem Cell MobilizationEtoposideBone Marrow PurgingRecurrenceHodgkin DiseaseGraft vs Host DiseaseCarmustineHematopoietic Stem CellsCytarabineMyeloablative AgonistsLiver TransplantationSurvival RateWhole-Body IrradiationGraft SurvivalSurvival AnalysisHematologic NeoplasmsSpleenVincristineAntigens, CD34Retrospective StudiesBusulfanThiotepaPrognosisGranulocyte Colony-Stimulating FactorDoxorubicinKidney TransplantationFollow-Up StudiesDexamethasoneTime FactorsLymphoma, Mantle-CellLeukapheresisAmyloidosisCell TransplantationBone and BonesAntineoplastic Agents, AlkylatingAntibodies, Monoclonal, Murine-DerivedThalidomideTransplantation ChimeraBoronic AcidsPyrazinesLymphomaAntineoplastic AgentsTissue DonorsMesenchymal Stem Cell TransplantationLymphoma, FollicularLymphoma, T-Cell, PeripheralPrednisoneNeoplasm, ResidualLeukemia, Myeloid, AcuteAutograftsHematopoiesisIfosfamideCord Blood Stem Cell TransplantationMyelodysplastic SyndromesHeart TransplantationImmunosuppressive AgentsCell DifferentiationInduction ChemotherapyPodophyllotoxinLung TransplantationLeukemiaIdarubicinLymphoma, Large B-Cell, DiffuseCells, CulturedAntibodies, MonoclonalBlood Component RemovalHistocompatibility TestingProspective StudiesMaintenance ChemotherapyFeasibility StudiesTransplantation ImmunologyGraft RejectionT-LymphocytesLymphoma, B-CellFlow CytometryHistocompatibilityLeukemia, MyeloidOrgan TransplantationBone Marrow DiseasesEmbryonic Stem Cells